Concurrent Investment Advisors LLC Makes New Investment in Oscar Health, Inc. (NYSE:OSCR)

Concurrent Investment Advisors LLC purchased a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,611 shares of the company's stock, valued at approximately $677,000.

A number of other institutional investors have also recently modified their holdings of the stock. World Investment Advisors purchased a new stake in shares of Oscar Health in the first quarter worth $205,000. Oppenheimer & Co. Inc. grew its stake in shares of Oscar Health by 4.6% in the first quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock worth $372,000 after acquiring an additional 1,250 shares during the last quarter. Prosperity Wealth Management Inc. grew its stake in shares of Oscar Health by 10.6% in the first quarter. Prosperity Wealth Management Inc. now owns 87,676 shares of the company's stock worth $1,149,000 after acquiring an additional 8,399 shares during the last quarter. Princeton Global Asset Management LLC purchased a new stake in shares of Oscar Health in the first quarter worth $59,000. Finally, Fiduciary Alliance LLC purchased a new stake in shares of Oscar Health in the first quarter worth $163,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director owned 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 24.39% of the company's stock.

Oscar Health Stock Performance

Shares of NYSE:OSCR traded down $1.13 during midday trading on Friday, reaching $14.40. 56,391,991 shares of the company's stock traded hands, compared to its average volume of 7,017,342. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The stock has a 50 day moving average of $16.30 and a 200 day moving average of $14.88. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88. The company has a market cap of $3.67 billion, a price-to-earnings ratio of 51.43 and a beta of 1.90.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The company had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the prior year, the company earned $0.62 earnings per share. Oscar Health's revenue was up 42.2% on a year-over-year basis. As a group, equities research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on OSCR. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Wells Fargo & Company cut Oscar Health from an "equal weight" rating to an "underweight" rating and cut their target price for the stock from $16.00 to $10.00 in a research note on Friday. Barclays initiated coverage on Oscar Health in a report on Wednesday, July 2nd. They set an "underweight" rating and a $17.00 price target on the stock. Piper Sandler lowered their price target on Oscar Health from $25.00 to $18.00 and set an "overweight" rating on the stock in a report on Monday, June 9th. Finally, Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a report on Sunday, June 8th. Four investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Oscar Health has an average rating of "Hold" and a consensus target price of $15.58.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.